Track Smith & Nephew plc — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Smith & Nephew plc SN.L Open Smith & Nephew plc in new tab

1122.00 GBX
P/E
20.98
EPS
0.53
Yield
2.53%
Safety Score
77
P/B
2.42
ROE
11.84
Beta
0.67
Target Price
1428.44 GBX
Loading chart...
Key Metrics
Earnings dateAug. 4, 2026
P/E20.98
EPS0.53
Book Value4.60
Price to Book2.42
Debt/Equity62.90
% Insiders0.225%
Growth
Revenue Growth0.07%
Earnings Growth0.70%
Estimates
Forward P/E12.09
Forward EPS0.92
Target Mean Price1428.44
Dividend
Dividend Yield2.53%
Annual dividends0.39 GBX
Ex-Div. DateMarch 26, 2026
Payout52.80%
5y avg Yield2.55%

DCF Valuation

Tweak assumptions to recompute fair value for Smith & Nephew plc (SN.L)
Currency: GBX
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Smith & Nephew plc Logo Smith & Nephew plc Analysis (SN.L)

United Kingdom Health Care Official Website Stock

Is Smith & Nephew plc a good investment? Smith & Nephew plc (SN.L) is currently trading at 1122.00 GBX. Market analysts have a consensus price target of 1428.44 GBX. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 20.98. This valuation is generally in line with the broader market.

Earnings Schedule: Smith & Nephew plc is expected to release its next earnings report on Aug. 4, 2026. The market consensus estimate for Forward EPS is 0.92.

For income investors, Smith & Nephew plc pays a dividend yield of 2.53%. With a payout ratio of 53%, the dividend appears sustainable.

Investor FAQ

Does Smith & Nephew plc pay a dividend?

Yes, it pays an annual dividend of 0.39 GBX (2.53% yield).

What asset class is Smith & Nephew plc?

Smith & Nephew plc is classified as a Stock. You can compare it against 5 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Aug. 4, 2026. The company currently has a trailing EPS of 0.53.

Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Exchange Ticker
LSE (United Kingdom) SN.L
STU (Germany) NPW1.SG
PNK (United States) SNNUF
FRA (Germany) NPW1.F
FRA (Germany) NPWA.F
Dividend Yield

2.53% (5y avg: 2.55%)

Annual Dividends

0.39 GBX

Next ex. div date

March 26, 2026

Payout Ratio

52.80%

Historical Dividends
Year Total Dividends
2026 18.26 GBX
2025 28.77 GBX
2024 37.50 GBX
2023 30.27 GBX
2022 31.31 GBX
2021 27.12 GBX
2020 29.73 GBX
2019 28.49 GBX
2018 26.91 GBX
2017 23.76 GBX
2016 23.08 GBX
2015 20.02 GBX
2014 16.93 GBX
2013 17.09 GBX
2012 13.01 GBX
2011 10.15 GBX
2010 9.66 GBX
2009 8.86 GBX
2008 6.58 GBX
2007 5.62 GBX
2006 5.71 GBX
2005 5.30 GBX
2004 5.00 GBX
2003 4.85 GBX
2002 4.70 GBX
2001 4.55 GBX
2000 43.73 GBX
1999 7.70 GBX
1998 7.58 GBX
1997 7.47 GBX
1996 7.06 GBX
1995 6.62 GBX
1994 6.16 GBX
1993 5.76 GBX

Yearly aggregated dividends

Dividends

Smith & Nephew plc
May 27, 2026 Upcoming
Dividend
18.12166 GBX
Smith & Nephew plc
Nov 07, 2025 Paid
Dividend
11.28711 GBX

Historical Split Corporate Actions

Split Date Split Ratio to 1
Aug. 7, 2000 0.820000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion